Robert Charles Breedlove - Principal Accounting Officer at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Principal Accounting Officer
Issuer Symbol
PHAT on Nasdaq
All Insider Reports
All Insider Reports

Robert Charles Breedlove - trading volume in the past year for Phathom Pharmaceuticals, Inc.

Holdings reported by Robert Charles Breedlove for Phathom Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47,068 $640,595 $13.61 21 Jan 2026 Direct
Common Stock 6,945 $115,229 $16.59 21 Jan 2026 By 401(k)
Stock Option (Right to Buy) 33,000 19 May 2025 Direct Common Stock

Transactions reported by Robert Charles Breedlove for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.